EP3984538
Mígalastat til notkunar við meðhöndlun á Fabrys-sjúkdómi í sjúklingum sem hafa stökkbreytingu í GLA-geninu
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
7.8.2020EP published:
5.11.2025EP application number:
21197291.4
EP translation filed:
30.1.2026Grant published:
11.2.2026EPO information:
European Patent Register
Max expiry date:
6.8.2040Expiry date:
6.8.2026
Title in English:
MIGALASTAT FOR USE IN TREATING FABRY DISEASE IN PATIENTS HAVING A MUTATION IN THE GLA GENELanguage of the patent:
English
Timeline
Today
7.8.2020EP application
5.11.2025EP Publication
30.1.2026Translation submitted
11.2.2026Registration published
6.8.2026Expires
Owner
Name:
Amicus Therapeutics, Inc.Address:
3675 Market Street, Philadelphia, PA 19104, US
Inventor
Name:
BENJAMIN, ElfridaAddress:
Philadelphia, PA 19104, US
Name:
WU, XiaoyangAddress:
Philadelphia, PA 19104, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201962883756 PDate:
7.8.2019Country:
US
Number:
202062986297 PDate:
6.3.2020Country:
US
Classification
Categories:
A61K 31/445, A61P 3/00